SEED Therapeutics Inc. ("SEED"), a biotechnology company pioneering targeted protein degradation (TPD) through the discovery ...

Learn about May 2025’s top biotech deals, featuring major collaborations in RNA interference technology, small molecules, and ...

For the past three decades, collaborations, deals and best practice exchanges on innovation and commercialisation have been a ...

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

Lilly’s Kisunla is the first amyloid-targeting therapy for Alzheimer’s registered in the country. Credit: JHVEPhoto/Shutterstock. Eli Lilly and Company has received marketing authorisation from the ...

Newly joining Season 2 are Dichen Lachman (“Severance”) as Yangchen, Dolly de Leon (“Triangle of Sadness”) as Lo and Li, Terry Chen (“Lucky Star”) as Jeong Jeong, Lily Gao (“Blue Sun ...

Languages: English. Missing children Lilly and Jack Sullivan and the people searching for them are facing "unbelievable conditions," according to the Nova Scotia Ground Search and Rescue ...

INDIANAPOLIS — Former Eli Lilly and Co. CEOs John Lechleiter and Randall Tobias, and their wives Deborah and Sarah, have partnered on a $20 million gift to establish the Tobias-Lechleiter Institute ...

As Eli Lilly and Novo Nordisk continue to go in opposite directions in their diabetes and obesity market rivalry, so too have they changed positions in the annual IDEA Pharma Innovation Index ...

To make the world smarter, happier, and richer. Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches ...

Eli Lilly (NYSE: LLY) is encouraged by trial data for its latest weight-loss and diabetes medications. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 ...

Eli Lilly is evaluating a massive $5.9 billion biomanufacturing facility in northeast Houston, potentially anchoring a new era in the city’s biotech future. The proposed plant would land in Generation ...